These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 27182739)
1. Axl Expression Stratifies Patients with Poor Prognosis after Hepatectomy for Hepatocellular Carcinoma. Liu J; Wang K; Yan Z; Xia Y; Li J; Shi L; Zou Q; Wan X; Jiao B; Wang H; Wu M; Zhang Y; Shen F PLoS One; 2016; 11(5):e0154767. PubMed ID: 27182739 [TBL] [Abstract][Full Text] [Related]
2. Axl and autophagy LC3 expression in tumors is strongly associated with clinical prognosis of hepatocellular carcinoma patients after curative resection. Hsu CC; Hsieh PM; Chen YS; Lo GH; Lin HY; Dai CY; Huang JF; Chuang WL; Chen YL; Yu ML; Lin CW Cancer Med; 2019 Jul; 8(7):3453-3463. PubMed ID: 31094090 [TBL] [Abstract][Full Text] [Related]
3. Axl Is a Potential Cancer Prognostic Marker for the Migration and Invasion of Nasopharyngeal Carcinoma. Jiang C; Zhou L; Wang H; Zhang Q; Xu Y Adv Clin Exp Med; 2016; 25(3):531-7. PubMed ID: 27629742 [TBL] [Abstract][Full Text] [Related]
4. Expression and prognostic role of ubiquitination factor E4B in primary hepatocellular carcinoma. Zhang XF; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Wang DD; Jiang SS; Zheng HX; Lv L; Chen CL; Zhang HX; Xia JC Mol Carcinog; 2016 Jan; 55(1):64-76. PubMed ID: 25557723 [TBL] [Abstract][Full Text] [Related]
5. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients. Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282 [TBL] [Abstract][Full Text] [Related]
6. Skipping of exon 10 in Shen L; Lei S; Zhang B; Li S; Huang L; Czachor A; Breitzig M; Gao Y; Huang M; Mo X; Zheng Q; Sun H; Wang F Theranostics; 2020; 10(13):5719-5735. PubMed ID: 32483414 [TBL] [Abstract][Full Text] [Related]
7. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression. Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879 [TBL] [Abstract][Full Text] [Related]
8. Axl is a prognostic marker in oral squamous cell carcinoma. Lee CH; Yen CY; Liu SY; Chen CK; Chiang CF; Shiah SG; Chen PH; Shieh YS Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S500-8. PubMed ID: 21842265 [TBL] [Abstract][Full Text] [Related]
9. MCM6 promotes metastasis of hepatocellular carcinoma via MEK/ERK pathway and serves as a novel serum biomarker for early recurrence. Liu M; Hu Q; Tu M; Wang X; Yang Z; Yang G; Luo R J Exp Clin Cancer Res; 2018 Jan; 37(1):10. PubMed ID: 29357919 [TBL] [Abstract][Full Text] [Related]
10. AXL Knock-Out in SNU475 Hepatocellular Carcinoma Cells Provides Evidence for Lethal Effect Associated with G2 Arrest and Polyploidization. Batur T; Argundogan A; Keles U; Mutlu Z; Alotaibi H; Senturk S; Ozturk M Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948046 [TBL] [Abstract][Full Text] [Related]
11. Decreased expression of long non-coding LOC285194 predicts tumour progression and poor prognosis of hepatocellular carcinoma after curative hepatectomy. Qiu J; Pan G; Li M Postgrad Med J; 2020 Feb; 96(1132):79-83. PubMed ID: 31494574 [TBL] [Abstract][Full Text] [Related]
12. Axl gene knockdown inhibits the metastasis properties of hepatocellular carcinoma via PI3K/Akt-PAK1 signal pathway. Xu J; Jia L; Ma H; Li Y; Ma Z; Zhao Y Tumour Biol; 2014 Apr; 35(4):3809-17. PubMed ID: 24347489 [TBL] [Abstract][Full Text] [Related]
13. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection. Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469 [TBL] [Abstract][Full Text] [Related]
14. H2.0-like homeobox 1 acts as a tumor suppressor in hepatocellular carcinoma. Liu T; Chen J; Xiao S; Lei X Tumour Biol; 2016 May; 37(5):6419-28. PubMed ID: 26631039 [TBL] [Abstract][Full Text] [Related]
15. Revealing the clinical significance and prognostic value of small nucleolar RNA SNORD31 in hepatocellular carcinoma. Ding Y; Sun Z; Zhang S; Xu Q; Zhou L; Zhou D; Li Y; Han X; Xu H; Bai Y; Xu C; Ding H; Ge Y; Wang W Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32697317 [TBL] [Abstract][Full Text] [Related]
16. Upregulation of liver kinase B1 predicts poor prognosis in hepatocellular carcinoma. Tan X; Liao Z; Liang H; Chen X; Zhang B; Chu L Int J Oncol; 2018 Nov; 53(5):1913-1926. PubMed ID: 30226588 [TBL] [Abstract][Full Text] [Related]
17. Increased Expression of SETD7 Promotes Cell Proliferation by Regulating Cell Cycle and Indicates Poor Prognosis in Hepatocellular Carcinoma. Chen Y; Yang S; Hu J; Yu C; He M; Cai Z PLoS One; 2016; 11(5):e0154939. PubMed ID: 27183310 [TBL] [Abstract][Full Text] [Related]
18. AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma. Xu MZ; Chan SW; Liu AM; Wong KF; Fan ST; Chen J; Poon RT; Zender L; Lowe SW; Hong W; Luk JM Oncogene; 2011 Mar; 30(10):1229-40. PubMed ID: 21076472 [TBL] [Abstract][Full Text] [Related]
19. MBD2 as a novel marker associated with poor survival of patients with hepatocellular carcinoma after hepatic resection. Liu W; Wang N; Lu M; Du XJ; Xing BC Mol Med Rep; 2016 Aug; 14(2):1617-23. PubMed ID: 27315121 [TBL] [Abstract][Full Text] [Related]
20. High expression of thymosin beta 10 predicts poor prognosis for hepatocellular carcinoma after hepatectomy. Wang H; Jiang S; Zhang Y; Pan K; Xia J; Chen M World J Surg Oncol; 2014 Jul; 12():226. PubMed ID: 25037578 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]